| Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function A Boni, AP Cogdill, P Dang, D Udayakumar, CNJ Njauw, CM Sloss, ... Cancer research 70 (13), 5213-5219, 2010 | 802 | 2010 |
| Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling U McDermott, SV Sharma, L Dowell, P Greninger, C Montagut, J Lamb, ... Proceedings of the National Academy of Sciences 104 (50), 19936-19941, 2007 | 401 | 2007 |
| Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families CNJ Njauw, I Kim, A Piris, M Gabree, M Taylor, AM Lane, MM DeAngelis, ... PloS one 7 (4), e35295, 2012 | 275 | 2012 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 222 | 2018 |
| Differentiation syndrome associated with enasidenib, a selective inhibitor of mutant isocitrate dehydrogenase 2: analysis of a phase 1/2 study AT Fathi, CD DiNardo, I Kline, L Kenvin, I Gupta, EC Attar, EM Stein, ... JAMA oncology 4 (8), 1106-1110, 2018 | 187 | 2018 |
| Genotypic and phenotypic features of BAP1 cancer syndrome: a report of 8 new families and review of cases in the literature AM Haugh, CN Njauw, JA Bubley, AE Verzì, B Zhang, E Kudalkar, ... JAMA dermatology 153 (10), 999-1006, 2017 | 110 | 2017 |
| EphA2 is a critical oncogene in melanoma D Udayakumar, G Zhang, Z Ji, CN Njauw, P Mroz, H Tsao Oncogene 30 (50), 4921-4929, 2011 | 100 | 2011 |
| p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition Z Ji, CN Njauw, M Taylor, V Neel, KT Flaherty, H Tsao Journal of investigative dermatology 132 (2), 356-364, 2012 | 92 | 2012 |
| MITF modulates therapeutic resistance through EGFR signaling Z Ji, YE Chen, R Kumar, M Taylor, CNJ Njauw, B Miao, DT Frederick, ... Journal of Investigative Dermatology 135 (7), 1863-1872, 2015 | 90 | 2015 |
| EphA2 Is an Essential Mediator of UV Radiation–Induced Apoptosis G Zhang, CN Njauw, JM Park, C Naruse, M Asano, H Tsao Cancer research 68 (6), 1691-1696, 2008 | 63 | 2008 |
| High MITF expression is associated with super-enhancers and suppressed by CDK7 inhibition in melanoma P Eliades, BJ Abraham, Z Ji, DM Miller, CL Christensen, N Kwiatkowski, ... Journal of Investigative Dermatology 138 (7), 1582-1590, 2018 | 58 | 2018 |
| Cloning and characterization of the pheromone biosynthesis activating neuropeptide receptor gene in Spodoptera littoralis larvae L Zheng, C Lytle, C Njauw, M Altstein, M Martins-Green Gene 393 (1-2), 20-30, 2007 | 56 | 2007 |
| Hypoxia and HIF-1α regulate collagen production in keloids Y Kang, MR Roh, S Rajadurai, A Rajadurai, R Kumar, CN Njauw, Z Zheng, ... Journal of Investigative Dermatology 140 (11), 2157-2165, 2020 | 55 | 2020 |
| Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma V Nikolaou, X Kang, A Stratigos, H Gogas, MC Latorre, M Gabree, ... British Journal of Dermatology 165 (6), 1219-1222, 2011 | 53 | 2011 |
| Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth Z Ji, R Kumar, M Taylor, A Rajadurai, A Marzuka-Alcalá, YE Chen, ... Clinical Cancer Research 19 (16), 4383-4391, 2013 | 48 | 2013 |
| Use of targeted next-generation sequencing to identify activating hot spot mutations in cherry angiomas N Klebanov, WM Lin, M Artomov, M Shaughnessy, CN Njauw, R Bloom, ... JAMA dermatology 155 (2), 211-215, 2019 | 30 | 2019 |
| Rare variant, gene-based association study of hereditary melanoma using whole-exome sequencing M Artomov, AJ Stratigos, I Kim, R Kumar, M Lauss, BY Reddy, B Miao, ... JNCI: Journal of the National Cancer Institute 109 (12), djx083, 2017 | 30 | 2017 |
| Multiple cutaneous melanomas and clinically atypical moles in a patient with a novel germline BAP1 mutation P Gerami, O Yélamos, CY Lee, R Obregon, P Yazdan, LM Sholl, ... JAMA dermatology 151 (11), 1235-1239, 2015 | 25 | 2015 |
| Cancer risks associated with the germline MITF (E318K) variant SM Guhan, M Artomov, S McCormick, CN Njauw, AJ Stratigos, K Shannon, ... Scientific Reports 10 (1), 17051, 2020 | 21 | 2020 |
| Classifying melanoma by TERT promoter mutational status M Shaughnessy, CN Njauw, M Artomov, H Tsao Journal of Investigative Dermatology 140 (2), 390-394. e1, 2020 | 21 | 2020 |
